Latest news with #NeogenChemicalsLtd
Yahoo
7 days ago
- Business
- Yahoo
Neogen Chemicals Ltd (BOM:542665) Q1 2026 Earnings Call Highlights: Resilience Amid Challenges ...
Release Date: August 04, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Neogen Chemicals Ltd (BOM:542665) demonstrated resilience by maintaining momentum despite operational challenges due to a fire incident. The company reported sustained volume growth in its base business, contributing to its financial performance. Initial commercial sales from Neogen Ionics for both electrolyte and lithium salts began contributing meaningfully to the company's revenue. The company has secured initial insurance claims of INR 50.55 crore in June 2025 and an additional INR 30 crore in July 2025, aiding recovery from the fire incident. Neogen Chemicals Ltd (BOM:542665) is making significant progress in its strategic growth drivers, particularly in the battery chemicals segment, with ongoing expansion initiatives. Negative Points The company faced operational hurdles due to a fire incident, impacting the availability of its H plant for the quarter. There is a prevailing soft pricing environment, which could affect profitability. The retirement of Chairman and Managing Director Mr. Haridas Kanani may lead to transitional challenges. The company adjusted its near-term revenue guidance to reflect current operational realities, indicating potential short-term financial pressure. There are delays in product approvals and customer audits, particularly affecting the ramp-up of export revenues. Q & A Highlights Warning! GuruFocus has detected 4 Warning Signs with BOM:542665. Q: What is the status of product approvals for the salt business, and how is the export revenue ramp-up progressing? A: We are ready from our side and waiting for the customer to schedule an audit. There have been delays from the customer side due to current events in the US. We are also ramping up our H capacity, which will increase to 2,500 metric tons by March. Meanwhile, we are generating small revenue by selling to non-regulated markets like China. (Respondent: Unidentified_3) Q: From a key end-user market perspective, will the US or Europe be bigger, and is there any change in demand due to tariff uncertainties? A: The US is the larger market due to established battery manufacturing activities. Despite changes in IRA, the 45X credits for cell makers remain, which require localization and a China-free supply chain. Interest from international markets is growing stronger, and more companies are approaching Neogen for partnerships. (Respondent: Unidentified_3) Q: What is the typical time lag required to increase salt capacity given the demand and interest? A: We are targeting 2,500 metric tons and can increase by 1,000 metric tons more, focusing on additives. We have room to add 1 KTA at the H facility and 2 additional KTA at Pahagen. We can add 3 KTA relatively quickly within 6 to 9 months, but beyond 8.5 KTA, it will take 12 to 15 months to set up a new manufacturing block. (Respondent: Unidentified_3) Q: Can you share the volume growth numbers for the first quarter across businesses? A: On the organic side, volume growth is around 10 to 15%. On the lithium side, there was a big growth last quarter, but Q1 was softer than usual. However, demand continues, and by the end of the year, lithium volumes should match or slightly exceed previous levels. (Respondent: Unidentified_3) Q: What is the purpose of the NCD issue, and is it for working capital or something else? A: The NCD issue is to ensure smooth CapEx execution and not be fully dependent on insurance claims. It provides additional liquidity to manage timing mismatches in insurance receipts and ongoing CapEx projects. The NCD issuance is expected to happen within the current month. (Respondent: Unidentified_3) For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Standard
04-08-2025
- Business
- Business Standard
Advanced Enzyme Technologies Ltd leads losers in 'A' group
Shakti Pumps (India) Ltd, Neogen Chemicals Ltd, Balaji Amines Ltd and Thermax Ltd are among the other losers in the BSE's 'A' group today, 04 August 2025. Shakti Pumps (India) Ltd, Neogen Chemicals Ltd, Balaji Amines Ltd and Thermax Ltd are among the other losers in the BSE's 'A' group today, 04 August 2025. Advanced Enzyme Technologies Ltd crashed 8.54% to Rs 329.5 at 14:46 stock was the biggest loser in the BSE's 'A' the BSE, 92278 shares were traded on the counter so far as against the average daily volumes of 32674 shares in the past one month. Shakti Pumps (India) Ltd tumbled 6.78% to Rs 832.95. The stock was the second biggest loser in 'A' the BSE, 3.43 lakh shares were traded on the counter so far as against the average daily volumes of 47449 shares in the past one month. Neogen Chemicals Ltd lost 6.35% to Rs 1439.85. The stock was the third biggest loser in 'A' the BSE, 3976 shares were traded on the counter so far as against the average daily volumes of 1365 shares in the past one month. Balaji Amines Ltd plummeted 6.28% to Rs 1584.7. The stock was the fourth biggest loser in 'A' the BSE, 14808 shares were traded on the counter so far as against the average daily volumes of 7595 shares in the past one month. Thermax Ltd shed 6.01% to Rs 3549.7. The stock was the fifth biggest loser in 'A' the BSE, 7331 shares were traded on the counter so far as against the average daily volumes of 14343 shares in the past one month.
Business Upturn
04-08-2025
- Business
- Business Upturn
Neogen Chemicals shares drop over 3% as Q1 net profit declines 10.5% YoY to Rs 10.3 crore
By Aman Shukla Published on August 4, 2025, 09:56 IST Neogen Chemicals Ltd shares slipped over 3% in morning trade on August 4 after the company reported a muted set of numbers for the first quarter of FY26. The stock opened at ₹1,539.80 and touched an intraday low of ₹1,490.00. As of 9:54 AM, the shares were trading 2.77% lower at Rs 1,497.20. On a consolidated basis, the specialty chemicals company posted a 3.8% rise in revenue at ₹187 crore compared to ₹180 crore in the year-ago period. EBITDA grew marginally by 2.3% to ₹31.5 crore from ₹30.8 crore, while EBITDA margins came in at 16.9%, slightly lower than 17.1% in Q1FY25. However, the bottom line took a hit, with net profit dropping 10.5% YoY to ₹10.3 crore, down from ₹11.5 crore in the same quarter last year. Neogen Chemicals' stock has seen significant volatility over the past year. The shares are currently trading well below their 52-week high of ₹2,420.00, but remain above the 52-week low of ₹1,392.75, indicating a broader range-bound movement in recent months. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
